Key result
High pretest probability for HFpEF in patients with group 3 or 4 pulmonary hypertension was associated with higher resting and dynamic PCWP responses to NO, fluid, and exercise.
Why the study?
Many patients with lung disease, sleep apnea, and chronic thromboemboli have risk factors for HFpEF, but the optimal approach to identify the disease overlap remains unclear.
Does the HFpEF-ABA algorithm identify occult HFpEF and correlate with dynamic PCWP abnormalities and functional status in patients with group 3 or 4 pulmonary hypertension?
Observational (n=792)
Does the HFpEF-ABA algorithm identify occult HFpEF and correlate with dynamic PCWP abnormalities and functional status in patients with group 3 or 4 pulmonary hypertension?
Answers are grounded in this paper and cite their sources.
Quantifying pretest probability for HFpEF using the HFpEF-ABA algorithm identifies subclinical left heart abnormalities and worse functional status in patients with group 3 or 4 pulmonary hypertension that are missed by resting right heart catheterization alone.
BACKGROUND: Patients with lung disease, sleep apnea, and chronic thromboemboli can develop pulmonary hypertension, currently classified as group 3 or 4. Many of these patients also have risk factors for heart failure with preserved ejection fraction (HFpEF), but the optimal approach to identify the disease overlap remains unclear. METHODS: Pretest probability for HFpEF was determined using the HFpEF-ABA (age, body mass index, atrial fibrillation) algorithm among adjudicated group 3 or 4 patients at risk for pulmonary hypertension in the PVDOMICS study (Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics). Patients were stratified by current resting right heart catheterization criteria, and in a separate analysis, stratified only by HFpEF-ABA probability into low (<25%), intermediate, and high (≥75%) HFpEF probability groups. RESULTS: Among 598 patients with group 3 disease, 27% (n=161) had elevated pulmonary capillary wedge pressure (PCWP) with postcapillary pulmonary hypertension even at rest, which was associated with the highest exercise PCWP. However, regardless of this resting PCWP-based classification, a larger subset had intermediate-to-high HFpEF-ABA probabilities (32% [n=197] high and 57% [n=358] intermediate HFpEF probability). High HFpEF probability in group 3 disease was associated with higher resting and dynamic PCWP response to NO, fluid, and exercise ( P <0.0001 for all). These changes were comparable with more traditionally defined HFpEF without pulmonary vascular disease (n=61) but less severe than those with combined precapillary and postcapillary pulmonary hypertension HFpEF (n=31; interaction P =0.006). Increasing HFpEF probability in group 3 disease was associated with worse left heart remodeling, quality of life, 6-minute walk distance, and peak VO 2 ( P <0.0001 for all). Findings were replicated in group 4 disease (n=102). CONCLUSIONS: Quantifying pretest probability for HFpEF in patients with sleep apnea, lung disease, or chronic thromboemboli identifies a progressive gradient for dynamic PCWP abnormalities with worse functional status and quality of life. These subclinical left heart abnormalities are not universally detectable by resting right heart catheterization alone and call for further study of whether strategies to prevent or treat HFpEF might improve functional status in these patients with high risk of occult HFpEF.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2025) conducted an observational in Lung disease, OSA, and chronic thromboemboli at risk for or with known pulmonary hypertension (n=792). High HFpEF-ABA pretest probability vs. Low HFpEF-ABA pretest probability was evaluated on Resting and dynamic PCWP response to NO, fluid, and exercise (p=<0.0001). High pretest probability for HFpEF in patients with group 3 or 4 pulmonary hypertension was associated with higher resting and dynamic PCWP responses to NO, fluid, and exercise.
Synapse has enriched 10 related papers. Consider them for comparative context: